Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse.
Timothy PapalucaMarie SinclairPaul GowStephen PiankoWilliam SievertNiranjan ArachchiKarla CameronScott BowdenJacinta O'KeefeJoseph DoyleMark StooveMargaret HellardDavid IserAlexander ThompsonPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
The combination of SOF/ELB/GZR ± RBV is effective and safe for difficult-to-cure patients who relapse after first-line DAA, including those with cirrhosis and GT3 infection.